Turn Biotechnologies

Turn Biotechnologies is a biotechnology company based in Mountain View, California. The company employs 30 people and generates over $10,000 in annual revenue. Turn Biotechnologies focuses on developing a reprogramming therapy aimed at rejuvenating aged human bodies. Their approach targets multiple aging-related indications by addressing the nine "Hallmarks of Aging" identified in a 2013 paper published in Cell. The company's proprietary cocktail of rejuvenation factors has demonstrated the ability to reverse eight of these hallmarks. Turn Biotechnologies differentiates itself through its innovative technology that aims to reverse the aging process. Their proprietary cocktail of rejuvenation factors represents a unique approach to combating age-related decline. For more information about Turn Biotechnologies and their groundbreaking research, visit their website at turn.bio.